Physician profile
Lisa Jancel
NPI 1184610156
$1,147.29
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was more than what 90% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.36 · 2023: $356 · 2024: $549 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $274.82 | 2023-2025 | Entyvio, Eohilia |
| Regeneron Healthcare Solutions, INC. | $186.96 | 2023-2024 | Dupixent |
| Ardelyx, INC. | $141.55 | 2023-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.04 | 2023-2025 | Trulance, Xifaxan |
| Merck Sharp & Dohme LLC | $85.44 | 2024 | Dificid, Bridion |
| Calyxo, INC. | $47.16 | 2025 | Cvac Aspiration System |
| Lilly USA, LLC | $45.79 | 2024-2025 | Omvoh |
| Nestle Healthcare Nutrition INC. | $45.10 | 2023 | |
| Braintree Laboratories, INC. | $43.65 | 2022-2024 | Sutab, Suflave |
| Janssen Biotech, INC. | $39.86 | 2024 | Stelara, Tremfya |
| Intercept Pharmaceuticals, INC. | $31.75 | 2023-2024 | Ocaliva |
| Celltrion USA INC. | $28.24 | 2024 | Zymfentra |
| Mindray Ds USA, INC. | $25.51 | 2024 | A7 Anesthesia System |
| Pacira Pharmaceuticals Incorporated | $20.31 | 2025 | Exparel |
| Madrigal Pharmaceuticals | $15.11 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Jancel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.